New York, NY – July 9, 2026 – Ozari Health (ozarihealth.com), a LegitScript-certified GLP-1 telehealth platform, today published a full transparency review of its clinical credentials, pharmacy standards, and pricing – developed to help patients evaluate online GLP-1 providers with confidence as demand for affordable access continues to grow.
GLP-1 receptor agonists have drawn significant clinical attention in recent years. The STEP 1 trial, published in the New England Journal of Medicine in 2021, demonstrated a mean body weight reduction of 14.9% over 68 weeks among participants receiving semaglutide. The SURMOUNT-1 trial, published in 2022, found a mean weight reduction of 20.9% at the highest studied tirzepatide dose over 72 weeks. Brand-name versions of these medications carry list prices exceeding $1,000 per month, creating a substantial access gap for the millions of Americans without adequate insurance coverage for GLP-1 treatment.
As the online GLP-1 market has expanded to address this gap, patients face a growing challenge: evaluating which providers meet the clinical, pharmacy, and pricing transparency standards that responsible telehealth requires. Ozari Health’s transparency review, published at ozarihealth.com/blog/is-ozari-health-legitimate-affordable-glp1, gives patients a six-point verification framework applicable to any online GLP-1 provider.
The six criteria covered in the review are:
1. Independent third-party certification. Ozari Health holds an active LegitScript certification, verifiable at legitscript.com.LegitScript certification requires ongoing compliance review and can be revoked — it is not self-reported.
2. Named, licensed clinical team. Ozari’s clinical team includes a board-certified Medical Director, a licensed Family Nurse Practitioner, and a bilingual licensed pharmacist — all independently verifiable through public licensing databases.
3. Licensed provider review before every prescription. Every patient completes a clinical intake reviewed by a licensed provider before any prescription is issued. Not every patient who applies will be approved.
4. Named, US-licensed pharmacy partners. Medications are dispensed only under valid patient-specific prescriptions through named 503A compounding pharmacies whose licenses patients can independently verify through state pharmacy boards.
5. Published all-in pricing. Compounded semaglutide from $86 per month and compounded tirzepatide from $125 per month for eligible patients — with no hidden membership fees and no long-term contract required. Full pricing is available at ozarihealth.com/treatments/semaglutide and ozarihealth.com/treatments/tirzepatide before patients commit.
6. Accurate medication language. Ozari clearly discloses that compounded medications are not FDA-approved and are not generic versions of Ozempic, Wegovy, Mounjaro, or Zepbound — a distinction that matters clinically and legally.
The review includes a side-by-side comparison table of practices that distinguish transparent GLP-1 providers from those that do not meet clinical or pharmacy standards, along with direct verification links for every credential listed.
This resource follows Ozari Health’s previously published GLP-1 Telehealth Pricing Index — a public dataset tracking all-in monthly pricing across more than 90 US online GLP-1 providers, available at ozarihealth.com/glp1-data and on Hugging Face at huggingface.co/datasets/Ozarihealth/glp1-telehealth-pricing-2026— and the company’s 2026 Checklist for Choosing an Online GLP-1 Provider.
The full transparency review is available at:ozarihealth.com/blog/is-ozari-health-legitimate-affordable-glp1
Spanish-language GLP-1 resources are available at:ozarihealth.com/es/blog
Frequently Asked Questions
Is Ozari Health a legitimate GLP-1 provider?
Yes. Ozari Health holds active LegitScript certification, requires licensed provider review before any prescription is issued, works with named US-licensed compounding pharmacies, and publishesall-in pricing before patients commit. All credentials are independently verifiable.
How much does Ozari Health cost?
Compounded semaglutide starts at $86 per month and compounded tirzepatide starts at $125 per month for eligible starter-planpatients after licensed provider review. No hidden membership fees. No long-term contract required.
Are compounded GLP-1 medications from Ozari FDA-approved?
No. Compounded semaglutide and compounded tirzepatide are not FDA-approved and are not generic versions of Ozempic, Wegovy, Mounjaro, or Zepbound. Ozari Health discloses this clearly before patients commit to any treatment.
How can patients verify Ozari Health’s credentials?
LegitScript certification: legitscript.com. Clinical team licenses: NPI Registry at npiregistry.cms.hhs.gov. Full credential details and verification links at:ozarihealth.com/blog/is-ozari-health-legitimate-affordable-glp1
Does Ozari Health serve Spanish-speaking patients?
Yes. Ozari Health offers its full platform, patient intake, andclinician-reviewed GLP-1 resources in Spanish atozarihealth.com/es.
About Ozari Health
Ozari Health (ozarihealth.com) is a LegitScript-certified GLP-1telehealth platform connecting patients with licensed providers for personalized GLP-1 treatment plans. Compounded semaglutide from $86 per month and compounded tirzepatide from $125 per month for eligible patients — transparent all-in pricing, no hidden fees, no long-term contracts. Clinician-reviewed resources in English at ozarihealth.com/blog and in Spanish atozarihealth.com/es/blog.
Compounded semaglutide and compounded tirzepatide are not FDA-approved and are not generic equivalents of Ozempic, Wegovy, Mounjaro, or Zepbound. They are prepared by US-licensed compounding pharmacies under valid patient-specific prescriptions issued by licensed providers.
Media ContactCompany Name: Ozari HealthContact Person: Ozari Press TeamEmail: Send EmailCity: New YorkState: New YorkCountry: United StatesWebsite: www.ozarihealth.com
